Maze Therapeutics (MAZE) PT Raised to $34 at Guggenheim
Tweet Send to a Friend
(Updated - September 15, 2025 7:25 AM EDT)
Guggenheim analyst Debjit Chattopadhyay raised the price target on Maze Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Guggenheim analyst Debjit Chattopadhyay raised the price target on Maze Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
